Korean J Hematol 1997; 32(3):
Published online September 30, 1997
© The Korean Society of Hematology
이종화, 한지숙, 고윤웅, 임환섭
연세대학교 의과대학 내과학교실,
연세대학교 의과대학 임상병리학교실
Background: The purpose of this study is to evaluate the potential role of erythropoietin(EPO) in anemai of chronic infection or inflammation.
Method:
Anemia of chronic infection or inflammation, 33 cases from Yonsei Medical Center from September, 1993 to August, 1995 were compared with uncomplicated iron deficiency anemia(IDA) 32 cases with analyzing serum EPO levels.
Result:
1)Mean hemoglobin was higher in anemia of chronic infection or inflammation(10.6±0.9g/dL) than IDA(9.8±0.7g/dL)(P<0.05).
2)MCV value was higher in anemia of chronic infection or inflammation(88.6±7.6fL) than IDA(73.8±7.1fL)(P<0.05).
3)In anmia of chronic infection or inflammation, serum iron was 54.3±18.3μg/dL, TIBC 282.6±64.9μg/dL, iron saturation 15.9±4.6% and serum ferritin 403.4±179.5ng/mL. TIBC and serum ferritin were significantly different(P=0.0001 each) comparing with IDA (serum iron 44.8±28.7μg/dL, TIBC 421.1±70.3μg/dL, iron saturation 11.9±6.5%, serum ferritin 7.9±7.2ng/mL).
4)ESR was increased in anemia of chronic infection or inflammation(54.1±17.3mm/hr) than IDA(17.1±6.5mm/hr) with significance(P<0.05).
5)Serum EPO level was 18.9±9.0mU/mL in anemia of chronic or inflammation but 47.2±33.1mU/mL in IDA with significant difference(P<0.05).
6)The increments of serum EPO according to hemoglobin levels in anemia of chronic infection or inflammation was less than that of IDA and there was no correlation(r=-0.25).
Conclusion: In anemia of chronic infection or inflammation, the responses of serum EPO are inappropriately low and recombinant human EPO administration may be helpful to improve this type of anemia.
Keywords Serum erythropoietin, Anemia, Chronic infection, Chronic inflammaion
Korean J Hematol 1997; 32(3): 367-375
Published online September 30, 1997
Copyright © The Korean Society of Hematology.
이종화, 한지숙, 고윤웅, 임환섭
연세대학교 의과대학 내과학교실,
연세대학교 의과대학 임상병리학교실
Jong Hwa Lee, Jee Sook Hahn, Yun Woong Ko, Hwan Sup Yim
Department of Internal Medicine, Clinical Pathology, Yonsei University College of Medicine, Seoul, Korea
Background: The purpose of this study is to evaluate the potential role of erythropoietin(EPO) in anemai of chronic infection or inflammation.
Method:
Anemia of chronic infection or inflammation, 33 cases from Yonsei Medical Center from September, 1993 to August, 1995 were compared with uncomplicated iron deficiency anemia(IDA) 32 cases with analyzing serum EPO levels.
Result:
1)Mean hemoglobin was higher in anemia of chronic infection or inflammation(10.6±0.9g/dL) than IDA(9.8±0.7g/dL)(P<0.05).
2)MCV value was higher in anemia of chronic infection or inflammation(88.6±7.6fL) than IDA(73.8±7.1fL)(P<0.05).
3)In anmia of chronic infection or inflammation, serum iron was 54.3±18.3μg/dL, TIBC 282.6±64.9μg/dL, iron saturation 15.9±4.6% and serum ferritin 403.4±179.5ng/mL. TIBC and serum ferritin were significantly different(P=0.0001 each) comparing with IDA (serum iron 44.8±28.7μg/dL, TIBC 421.1±70.3μg/dL, iron saturation 11.9±6.5%, serum ferritin 7.9±7.2ng/mL).
4)ESR was increased in anemia of chronic infection or inflammation(54.1±17.3mm/hr) than IDA(17.1±6.5mm/hr) with significance(P<0.05).
5)Serum EPO level was 18.9±9.0mU/mL in anemia of chronic or inflammation but 47.2±33.1mU/mL in IDA with significant difference(P<0.05).
6)The increments of serum EPO according to hemoglobin levels in anemia of chronic infection or inflammation was less than that of IDA and there was no correlation(r=-0.25).
Conclusion: In anemia of chronic infection or inflammation, the responses of serum EPO are inappropriately low and recombinant human EPO administration may be helpful to improve this type of anemia.
Keywords: Serum erythropoietin, Anemia, Chronic infection, Chronic inflammaion
Jeong Suk Koh and Ik‑Chan Song
Blood Res 2024; 59():Ka‑Won Kang
Blood Res 2024; 59():Junshik Hong, Yoo Jin Lee, Sung Hwa Bae, Jun Ho Yi, Sungwoo Park, Myung Hee Chang, Young Hoon Park, Shin Young Hyun, Joo-Seop Chung, Ji Eun Jang, Joo Young Jung, So-Yeon Jeon, Seo-Young Song, Hawk Kim, Dae Sik Kim, Sung-Hyun Kim, Min Kyoung Kim, Sang Hoon Han, Seonyang Park, Yoo-Jin Kim, Je-Hwan Lee, on behalf of the AML/MDS Working Party of the Korean Society of Hematology
Blood Res 2021; 56(2): 102-108